ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

IGC IGC Pharma Inc

0.48
0.05 (11.63%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
IGC Pharma Inc IGC AMEX 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.05 11.63% 0.48 08:51:12
개장가 저가 고가 종가 전일 종가
0.421 0.417551 0.496 0.458 0.43
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202420:00BWIGC-AD1’s Interim Phase 2 Data Show a Reduction in..
09/04/202422:00BWIGC Pharma Adds Advisor in Artificial Intelligence
27/03/202404:00BWIGC Pharma Announces $3 Million Unregistered Private..
21/03/202400:00BWIGC Pharma Announces Positive Interim Results for IGC-AD1 in..
20/03/202420:00BWIGC PHARMA Announces its Participation at the Benzinga..
13/03/202404:00BWIGC Pharma (IGC): Healthcare Leader Terry Lierman Joins..
29/02/202403:00BWPromising Results: TGR-63 Enhances Memory in Alzheimer's..
24/02/202402:01BWIGC Pharma Announces Equity Analyst Coverage by Ascendiant..
17/02/202409:05BWIGC Pharma Reports Third Quarter Fiscal 2024 Results
15/02/202406:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/02/202423:20BWIGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's..
01/02/202406:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/01/202423:20BWIGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63..
17/01/202423:20BWIGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing..
09/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
30/12/202306:54EDGAR2Form S-3 - Registration statement under Securities Act of..
19/12/202323:20BWPatent Granted to IGC Pharma for Groundbreaking Drug..
13/12/202323:30BWIGC Pharma Announces Participation in Biotech Showcase and..
06/12/202322:30BWIGC Pharma Announces Collaboration to Integrate AI into..
21/11/202322:30BWIGC Pharma Announces Master Agreement with Leading South..
13/11/202322:00BWIGC Pharma Reports Second Quarter Fiscal 2024 Results
10/11/202307:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/10/202306:21EDGAR2Form 8-K - Current report
28/10/202305:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/10/202304:30BWIGC Pharma Granted European Patent for Groundbreaking..
30/09/202306:23EDGAR2Form S-3 - Registration statement under Securities Act of..
22/08/202303:30BWIGC Announces Results of its 2023 Annual Stockholders..
22/08/202301:44EDGAR2Form 8-K - Current report
14/08/202321:30BWIGC Pharma Reports First Quarter Results; Company Continues..
11/08/202305:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/08/202321:30BWIGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the..
27/07/202306:26EDGAR2Form DEF 14A - Other definitive proxy statements
18/07/202318:22BWIGC Pharma, Inc. Presenting 6 Posters on the Positive Impact..
12/07/202321:44BWIGC Reports Financial Results for Fiscal Year Ended March..
08/07/202305:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/07/202300:41EDGAR2Form 8-K - Current report
07/07/202322:15BWIGC Pharma Secures $12 Million Line of Credit from O-Bank..
06/07/202320:46BWIGC Pharma Announces a $3 Million Private Placement of its..
01/07/202305:03EDGAR2Form NT 10-K - Notification of inability to timely file Form..
29/06/202310:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202302:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/06/202322:20BWIGC Pharma Receives Notice of Allowance for Patent on..
05/06/202321:30BWIGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63..

최근 히스토리

Delayed Upgrade Clock